Kathryn Ruf, PharmD, MBA

Director of the Office of Pharmacy Value and Analytics
UK HealthCare

Poster(s):

• (1389) Healthcare-Wide Deployment of Intranasal Naloxone
  Tuesday, January 23, 2024

  8:45 AM – 9:45 AM MT